9 research outputs found
Imbalanced expression of functional surface molecules in regulatory and effector T cells in systemic lupus erythematosus
Get PDFComputerized tomography-based predictive model for differentiation of Crohn’s disease from intestinal tuberculosis
No full textEffects of simplified ethanol–wet bonding and hydrophobic coating on resin–dentin bonding properties
No full textComposition of the peninsular India rivers average clay (PIRAC): A reference sediment composition for the upper crust from peninsular India
No full textQuantitative Assessment of apically Extruded Bacteria using different Instrumentation Techniques and Preparation Taper
No full textMutated and Bacteriophage T4 Nanoparticle Arrayed F1-V Immunogens from Yersinia pestis as Next Generation Plague Vaccines
No full textMetabolomic biomarkers in mental disorders : bipolar disorder and schizophrenia
No full textPsychiatric disorders are some of the most impairing human diseases. Among them, bipolar disorder and schizophrenia are the most common. Both have complicated diagnostics due to their phenotypic, biological, and genetic heterogeneity, unknown etiology, and the underlying biological pathways, and molecular mechanisms are still not completely understood. Given the multifactorial complexity of these disorders, identification and implementation of metabolic biomarkers would assist in their early detection and diagnosis and facilitate disease monitoring and treatment responses. To date, numerous studies have utilized metabolomics to better understand psychiatric disorders, and findings from these studies have begun to converge. In this chapter, we briefly describe some of the metabolomic biomarkers found in these two disorders111827129
